NYSE:RMD - ResMed Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$101.24 +1.14 (+1.14 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$100.10
Today's Range$100.08 - $101.46
52-Week Range$90.64 - $118.50
Volume604,000 shs
Average Volume1.30 million shs
Market Capitalization$14.51 billion
P/E Ratio28.68
Dividend Yield1.48%

Analyst Ratings

ResMed (NYSE:RMD) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for ResMed in the last 12 months. Their average twelve-month price target is $109.80, suggesting that the stock has a possible upside of 8.46%. The high price target for RMD is $120.00 and the low price target for RMD is $99.60. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.222.302.222.00
Ratings Breakdown: 1 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $109.80$127.00$109.00$68.80
Price Target Upside: 8.46% upside8.11% upside6.03% upside33.58% downside

ResMed (NYSE:RMD) Consensus Price Target History

Price Target History for ResMed (NYSE:RMD)

ResMed (NYSE:RMD) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/28/2019BMO Capital MarketsLower Price TargetOutperform ➝ Positive$120.00HighView Rating Details
1/25/2019JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$99.60HighView Rating Details
1/25/2019Goldman Sachs GroupDowngradeBuy ➝ NeutralHighView Rating Details
1/23/2019Deutsche BankDowngradeBuy ➝ HoldLowView Rating Details
10/26/2018Credit Suisse GroupUpgradeNeutral ➝ OutperformHighView Rating Details
4/24/2018UBS GroupDowngradeBuy ➝ NeutralMediumView Rating Details
4/16/2018William BlairReiterated RatingOutperformLowView Rating Details
4/4/2018CitigroupDowngradeBuy ➝ NeutralMediumView Rating Details
3/7/2018Needham & Company LLCReiterated RatingHoldMediumView Rating Details
1/23/2018Northland SecuritiesUpgradeUnder Perform ➝ Market PerformHighView Rating Details
1/23/2018MacquarieDowngradeNeutral ➝ SellHighView Rating Details
10/27/2017BarclaysBoost Price TargetUnderweight$68.00 ➝ $70.00N/AView Rating Details
10/12/2017Jefferies Financial GroupReiterated RatingSell$56.00N/AView Rating Details
8/2/2017Bank of AmericaDowngradeBuy ➝ NeutralHighView Rating Details
(Data available from 2/22/2017 forward)
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel